What is KRYS stock price today?

KRYS (Krystal Biotech Inc) stock is trading at $267.41 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is KRYS stock going up or down today?

KRYS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KRYS stock now?

The decision to buy KRYS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KRYS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KRYS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KRYS stock overvalued or undervalued?

KRYS currently trades at a P/E ratio of 37.87, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if KRYS is fairly priced.

What is KRYS's P/E ratio?

KRYS has a price-to-earnings (P/E) ratio of 37.87, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is KRYS's market cap?

KRYS (Krystal Biotech Inc) has a market capitalization of $7.62 billion, making it a small-cap stock.

What is KRYS's price to book ratio?

KRYS trades at a price-to-book (P/B) ratio of 6.25, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KRYS pay dividends?

KRYS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KRYS's dividend yield?

KRYS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KRYS stock a good long-term investment?

KRYS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KRYS's revenue growth rate?

KRYS has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, KRYS is profitable with a profit margin of 0.5%. This indicates the company generates 0.5 cents of profit for every dollar of revenue.

What are the risks of investing in KRYS?

Key risks for KRYS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KRYS compare to its competitors?

Compare KRYS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KRYS's performance and positioning.

What is KRYS's stock price target for 2026?

Our AI model provides price targets for KRYS based on fundamental analysis: Bull case $347.63 (+30%), Base case $307.52 (+15%), Bear case $240.67 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about KRYS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KRYS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KRYS's next earnings report?

KRYS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KRYS - Krystal Biotech Inc

NYSE * Health Care * Biotechnology

$267.41

+$8.41 (+3.25%)

About Krystal Biotech Inc

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS Key Statistics

Market Cap

$7.62B

P/E Ratio

37.87

P/B Ratio

6.25

EPS

$6.84

Revenue Growth

+0.2%

Profit Margin

0.5%

Employees

295

How KRYS Compares to Peers

KRYS trades at a premium valuation vs peers (highest P/E)

KRYS has the highest profit margins in Biotechnology

KRYS has the fastest revenue growth among competitors

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
KRYS(This stock)	$7.62B	37.9	0%	0.5%	-
AMGNAmgen Inc	$188.58B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$172.56B	20.5	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$111.93B	28.7	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.92B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$25.88B	20.1	-0%	0.1%	vs BIIB

Krystal Biotech Inc Company Information

Headquarters: Pennsylvania; U.S.A
Website: www.krystalbio.com
Sector: Health Care
Industry: Biotechnology

KRYS - Krystal Biotech Inc

About Krystal Biotech Inc

KRYS Key Statistics

How KRYS Compares to Peers

Krystal Biotech Inc Company Information

KRYS Lician Score

KRYS Financial Snowflake

Upcoming Events for KRYS